The test is intended for use by laboratories to screen individual donations of blood and plasma for antibodies to human T-lymphotropic virus type I and/or human T-lymphotropic virus type II (anti-HTLV-I/HTLV-II).
Robert Doss, divisional vice president, diagnostics R&D, Abbott, said: “With the Abbott Prism system, we continue to support the infectious disease testing needs of the laboratory while helping them realize greater efficiencies and enhanced operator safety throughout the blood and plasma screening process.”